Blue Owl Capital Holdings »

Freeline Therapeutics Holdings shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Freeline Therapeutics Holdings shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Freeline Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Freeline Therapeutics Holdings held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Freeline Therapeutics Holdings by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $552k 87k 6.37

More positions owned by Blue Owl Capital Holdings

Pliant Therapeutics (PLRX)
Robinhood Mkts Com Cl A (HOOD)
Cullinan Oncology (CGEM)
Tourmaline Bio (TRML)
Klaviyo Com Ser A (KVYO)
Owl Rock Capital Corporation (OBDC)
Repare Therapeutics Ord (RPTX)
Acelyrin (SLRN)
Larimar Therapeutics (LRMR)
Keros Therapeutics (KROS)
Ultragenyx Pharmaceutical (RARE)
Engene Holdings (ENGN)
Syros Pharmaceuticals Com New (SYRS)
Disc Medicine (IRON)
E2open Parent Holdings Com Cl A (ETWO)

View all positions for Blue Owl Capital Holdings

Top funds holding Freeline Therapeutics Holdings

UBS Group
Blue Owl Capital Holdings
Jpmorgan Chase & Co
PenderFund Capital Management
Harbor Capital Advisors
Sphera Funds Management
Rhumbline Advisers

View all funds holding Freeline Therapeutics Holdings